Tickers

1. Composite Trajectory Verdict

Given ALCO's strategic wind-down of its citrus operations and transition to a land-management model, the income statement carries the most weight for assessing the earnings impact of that transformation, while the cash flow statement best reflects the liquidity generated from asset sales, and the balance sheet shows the residual asset base and leverage after impairments and sales.

Composite Trajectory: Mixed

The annual income statement deteriorated sharply in FY2025 versus FY2024, with revenue falling 5.5% to $44.1M and a net loss of $147.5M versus net income of $6.4M, driven by $162.7M of accelerated depreciation and a $25.0M long-lived asset impairment (10-K FY2025, Consolidated Statements of Operations). However, the most recent quarter (Q3 FY2026) swung to operating income of $1.9M from a $25.4M loss in Q3 FY2025, and nine-month operating income improved to $10.2M from a $173.4M loss (10-Q Q3 FY2026, MD&A). Cash flow from operations improved annually to $20.1M from -$30.5M but fell to $2.3M for nine months FY2026 versus $22.8M a year earlier due to lower crop insurance proceeds (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q3 FY2026, MD&A). The balance sheet shows cash rising from $3.2M to $38.1M to $55.6M, total assets halving from $398.7M to $201.5M to $198.7M, and debt roughly flat near $86M, with equity stabilizing around $105M after a $149M drop in FY2025 (10-K FY2025, Consolidated Balance Sheets; 10-Q Q3 FY2026, Consolidated Balance Sheets).

2. Red Flags

• Massive non-cash charges in FY2025: Accelerated depreciation of ~$162.7M and a $25.0M impairment drove the FY2025 net loss of $147.5M, but these are non-recurring wind-down charges (10-K FY2025, Note 5; Consolidated Statements of Cash Flows).
• Operating cash flow reliance on crop insurance: FY2025 operating cash flow of $20.1M included $20.4M of Hurricane Milton crop insurance proceeds; nine-month FY2026 operating cash flow fell to $2.3M without similar proceeds (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q3 FY2026, MD&A).
• Revenue collapse post wind-down: Nine-month FY2026 revenue dropped 62.4% to $16.3M from $43.3M as citrus operations ceased (10-Q Q3 FY2026, MD&A).
• Valuation allowance growth: Deferred tax asset valuation allowance rose from $5.8M at FY2024 to $14.1M at FY2025, with management citing a cumulative three-year loss position limiting realizability (10-K FY2025, Note 9).
• Debt covenant shift: The Seventh Amendment replaced multiple covenants with a Minimum Liquidity Requirement ($5.8M at FY2025, $5.8M at Q3 FY2026) and an LTV cap of 50%, increasing reliance on asset values (10-K FY2025, Note 8; 10-Q Q3 FY2026, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results deteriorated severely: FY2025 revenue fell 5.5% to $44.1M, gross loss widened to $192.2M from $56.4M, and net loss attributable to common stockholders was $147.3M versus $7.0M income in FY2024 (10-K FY2025, Consolidated Statements of Operations). The decline was driven by a 26.4% drop in pound solids produced, $162.7M accelerated depreciation, and a $25.0M impairment (10-K FY2025, MD&A; Note 5). Conversely, the quarterly trajectory improved markedly: Q3 FY2026 posted operating income of $1.9M versus a $25.4M loss in Q3 FY2025, and nine-month FY2026 operating income was $10.2M versus a $173.4M loss, as citrus wind-down costs ceased (10-Q Q3 FY2026, Condensed Consolidated Statements of Operations). Nine-month revenue fell 62.4% to $16.3M, reflecting the loss of citrus sales (10-Q Q3 FY2026, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

FY2025 operating cash flow turned positive at $20.1M from -$30.5M in FY2024, aided by $20.4M of crop insurance proceeds and a $16.0M inventory reduction from wind-down (10-K FY2025, Consolidated Statements of Cash Flows). However, nine-month FY2026 operating cash flow declined to $2.3M from $22.8M in the prior year period, primarily because the prior period included $20.0M of crop insurance proceeds (10-Q Q3 FY2026, MD&A). Investing cash flow remained positive in both periods from land sales: $24.1M in FY2025 (2,796 acres sold) and $28.2M in nine-month FY2026 (3,546 acres sold) (10-K FY2025, Note 4; 10-Q Q3 FY2026, MD&A). Financing cash flow was -$8.8M in FY2025 versus -$38.0M in FY2024, and -$13.1M in nine-month FY2026 versus -$8.1M, with the increase driven by $10.0M of share repurchases and a $2.0M Citree acquisition (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q3 FY2026, MD&A).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Cash and equivalents rose from $3.2M (FY2024) to $38.1M (FY2025) to $55.6M (Q3 FY2026) (10-K FY2025, Consolidated Balance Sheets; 10-Q Q3 FY2026, Consolidated Balance Sheets). Total assets declined from $398.7M to $201.5M to $198.7M, reflecting asset sales, impairments, and accelerated depreciation (same sources). Total debt (term loans plus lines of credit) was roughly stable at $92.6M, $86.0M, and $85.8M across the three dates (10-K FY2025, MD&A; 10-Q Q3 FY2026, MD&A). Total equity fell from $256.3M to $108.0M to $104.8M, with the FY2025 drop driven by the $147.5M net loss; noncontrolling interest was eliminated in Q3 FY2026 via the Citree purchase (10-K FY2025, Consolidated Statements of Changes in Equity; 10-Q Q3 FY2026, MD&A). The current ratio remained strong at 9.6x (FY2025) and 8.0x (Q3 FY2026) (10-K FY2025, MD&A; 10-Q Q3 FY2026, MD&A).

6. Data Gaps

• Stand-alone Q4 FY2025 and Q1–Q2 FY2026 income statements and cash flow statements (only FY2025 annual and Q3 FY2026 quarterly/YTD are provided).
• Detailed segment-level operating expense breakdown for the Land Management segment in FY2026 periods (consolidated into one segment after wind-down).
• Full-year FY2026 revenue, earnings, and cash flow run-rate post wind-down (only nine months available).
• Post-FY2025 debt maturity schedule beyond the amounts shown in the FY2025 10-K (Note 8) and Q3 FY2026 10-Q.
• Impact of the OBBBA tax legislation on future effective tax rates and deferred tax assets (noted as not reasonably estimable in 10-K FY2025, Note 9).